UNSPSC 51143408: Naproxen/sumatriptan

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

UNSPSC 51143408 Naproxen/sumatriptan is a Commodity code that shows a mismatch between its nominal pharmaceutical scope and the recent state and local procurement activity tagged under it. The single recent opportunity on record — Seminole County, Florida IFB 60459723LAS — solicits naloxone and safe drug deactivation systems for community health initiatives, not the migraine and pain-relief medications the code nominally covers. The work involves procurement of finished pharmaceutical products for public health distribution, with quarterly deliveries and fixed-fee pricing, but the specific drugs being purchased diverge from the code's stated scope. Issuing bodies under this code appear limited to county health and community agencies, based on the available record.

Seminole County, Florida represents the only recent geographic focal point in the available opportunities data. Seminole County Community Health released its naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2023, requiring electronic bid submission through the county's e-Procurement Portal. The contract calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a two-year initial term and one-year renewal option; vendors must include all shipping and delivery costs in their proposals and meet E-Verify compliance, drug-free workplace certification, and standard insurance requirements including workers' compensation and commercial general liability. The procurement indicates potential FEMA funding, which triggers additional federal compliance obligations. The code shows minimal recent activity overall — pursue this area only if your firm maintains product lines in emergency pharmaceutical distribution or opioid-reversal supply chains and can service Florida county health systems.